Pvg Asset Management »

Altimmune shares owned by Pvg Asset Management

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Pvg Asset Management from 13F filings

Historical chart of Pvg Asset Management investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Pvg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Pvg Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $145k 24k 6.14
2024-06-30 $154k 23k 6.65

More positions owned by Pvg Asset Management

SPDR Barclays Capital 1-3 month Etf (BIL)
ProShares UltraShort S&P 500 Etf (SDS)
Vanguard Index S&P 500 Etf (VOO)
S&p 500 Indx Etf (IVV)
Journey Med Corp (DERM)
Dynex Cap (DX)
Apa Corporation (APA)
Invesco ETF Tr S&P Equal Weighted Etf (RSP)
Macy's (M)
Invesco QQQ TR ETF SERIES 1 Etf (QQQ)
Fortress Biotech (FBIO)
Select Sector Spdr Trust Energ Etf (XLE)
Female Health (VERU)
Grail (GRAL)
Ishares S&p 500 Etf Growth Etf (IVW)

View all positions for Pvg Asset Management

Top funds holding Altimmune

BlackRock
Tang Capital Management
Susquehanna International
Geode Capital Management
Knoll Capital Management
Citadel Advisors
Bellevue Group
D. E. Shaw & Co
Dimensional Fund Advisors
Northern Trust
Jane Street
GSA Capital Partners
IMC-Chicago
Ensign Peak Advisors
Beirne Wealth Consulting Services

View all funds holding Altimmune